2025 Year 10 Month 28 On the day, as the second-phase factory's production line was fully launched, Jilin Province Zhongke Jingyan Health Industry Group reached another milestone in its development journey. The following morning ( 10 Month 29 On [Date], Liu Liying, Member of the Party Working Committee and Deputy Director of the Management Committee of the Economic Development Zone, accompanied by Han Xuefei, Deputy Director of the Pharmaceutical Industry Office of the Economic Development Zone and Director of the Seventh Bureau of Investment Promotion, visited the factory in person to inspect the achievements of the new plant construction. They also engaged in an in-depth discussion on enterprise innovation and development, as well as industrial chain collaboration, further boosting the growth of Zhongke Jingyan.

During the visit, Deputy Director Liu Liying and her delegation were accompanied by Sun Fa, Chairman of Zhongke Jingyan, as well as Executive Vice President Wang Lixin, and subsequently toured the 100,000-level pharmaceutical facility. GMP Standard production workshops, R&D laboratories, and an achievement showcase area—through on-site inspections, direct inquiries, and informal discussions—we gained a thorough understanding of the company’s production processes, core technologies, product application scenarios, and market expansion strategies.

In the production workshop, leaders carefully inspected key processes such as production line operations and quality control, praising Zhongke Jingyan for their strict adherence to standards. GMP A production philosophy that emphasizes standards and firmly upholds quality benchmarks has received high recognition;

In the R&D laboratory, upon learning that the company, as a unit dedicated to translating CAS medical research outcomes into practical applications, has consistently focused on advancing medical technology innovation and ensuring the successful implementation of its breakthroughs—while also building up a robust portfolio of core technologies—Vice Director Liu Liying expressed her admiration for the company's innovative spirit and strong R&D capabilities. She encouraged the enterprise to continue ramping up its investment in research and development, paving the way for overcoming even greater challenges ahead. “ Chokehold ”  Technical challenges.

The Chairman of Zhongke Jingyan engaged in an in-depth discussion, covering the company's development journey, its core business strategies, future growth plans, and the practical needs it currently faces. Director Liu Liying highly praised Zhongke Jingyan's remarkable achievements in recent years, particularly in areas such as translating medical research into practical applications and advancing healthcare technology innovation.

She pointed out that the pharmaceutical and healthcare industry is a strategic emerging sector that the Economic Development Zone is actively cultivating. As an important platform for translating scientific research achievements from the Chinese Academy of Sciences into practical applications, Zhongke Jingyan boasts a solid technological foundation, a standardized production system, and a clear development strategy—positions that position it with tremendous potential and promising prospects.

Addressing the needs of business development, Deputy Director Liu Liying stated that the Economic Development Zone will continue to support enterprise growth by providing even higher-quality services and fostering a more favorable environment for development. Relevant departments will further strengthen communication and collaboration with businesses, promptly identifying their challenges and requirements, offering assistance in resolving practical issues, and ensuring steady progress for corporate growth.

At the same time, she hopes that Zhongke Jingyan will continue to deepen its focus on core technologies, intensify its innovation efforts, accelerate the commercialization of research findings, and continuously enhance the company's core competitiveness. She encourages the team to strive toward becoming a benchmark enterprise in the pharmaceutical and healthcare industry, contributing even greater momentum to the high-quality development of the pharmaceutical and healthcare sector—both within the Economic Development Zone and across the broader region.

The Chairman of Zhongke Jingyan expressed heartfelt gratitude to the Party Working Committee and Administrative Committee of the Economic Development Zone for their long-term care and support, adding that this visit highlighted the zone's strong commitment to the pharmaceutical and healthcare industry, as well as its pragmatic and efficient service approach. Looking ahead, the company will seize this opportunity to further focus on its core business, strengthen innovation, accelerate R&D and the commercialization of scientific achievements, and strive relentlessly to deliver even higher-quality growth—living up to the trust and support of the Party Working Committee and Administrative Committee of the Economic Development Zone.

This exchange not only built a solid bridge for communication between government and enterprises, but also fostered a powerful synergy for collaborative development. We are confident that, with the precise support and strong backing from the Party Working Committee and Management Committee of the Economic Development Zone, Zhongke Jingyan will seize the momentum to achieve even greater success—and together with the Economic Development Zone, we will write a new chapter of high-quality growth in the pharmaceutical and healthcare industries!